Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) had its price target dropped by research analysts at Barclays from $39.00 to $36.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage presently has an "overweight" rating on the stock. Barclays's price objective would suggest a potential upside of 13.85% from the company's previous close.
Other analysts have also recently issued research reports about the stock. Wells Fargo & Company lowered their target price on shares of Keurig Dr Pepper from $42.00 to $40.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 7th. Jefferies Financial Group decreased their price objective on shares of Keurig Dr Pepper from $42.00 to $41.00 and set a "buy" rating on the stock in a research note on Friday, October 25th. Royal Bank of Canada lifted their price objective on shares of Keurig Dr Pepper from $41.00 to $42.00 and gave the company an "outperform" rating in a research note on Friday, October 25th. Piper Sandler initiated coverage on shares of Keurig Dr Pepper in a research note on Tuesday, January 7th. They issued a "neutral" rating and a $35.00 price objective on the stock. Finally, TD Cowen decreased their price objective on shares of Keurig Dr Pepper from $39.00 to $36.00 and set a "hold" rating on the stock in a research note on Wednesday, January 8th. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $37.50.
Check Out Our Latest Report on KDP
Keurig Dr Pepper Price Performance
Shares of NASDAQ KDP traded up $0.34 during trading on Friday, hitting $31.62. The company had a trading volume of 6,930,293 shares, compared to its average volume of 7,931,290. Keurig Dr Pepper has a 52 week low of $28.61 and a 52 week high of $38.28. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.36 and a current ratio of 0.53. The company has a market cap of $42.89 billion, a P/E ratio of 19.16, a PEG ratio of 2.20 and a beta of 0.62. The business's 50-day moving average is $32.28 and its 200 day moving average is $34.18.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings data on Thursday, October 24th. The company reported $0.51 earnings per share for the quarter, hitting the consensus estimate of $0.51. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The firm had revenue of $3.89 billion for the quarter, compared to analysts' expectations of $3.92 billion. During the same period in the previous year, the company posted $0.48 EPS. The company's quarterly revenue was up 2.3% compared to the same quarter last year. Equities research analysts predict that Keurig Dr Pepper will post 1.92 earnings per share for the current fiscal year.
Insider Buying and Selling at Keurig Dr Pepper
In related news, major shareholder Bevco B.V. Jab sold 69,000,000 shares of Keurig Dr Pepper stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $32.65, for a total transaction of $2,252,850,000.00. Following the completion of the transaction, the insider now directly owns 214,443,879 shares of the company's stock, valued at $7,001,592,649.35. This trade represents a 24.34 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.00% of the stock is currently owned by corporate insiders.
Institutional Trading of Keurig Dr Pepper
A number of large investors have recently made changes to their positions in the stock. Ashton Thomas Securities LLC bought a new stake in shares of Keurig Dr Pepper in the third quarter worth about $25,000. LRI Investments LLC bought a new position in Keurig Dr Pepper during the third quarter valued at $35,000. Hexagon Capital Partners LLC increased its position in Keurig Dr Pepper by 105.6% during the third quarter. Hexagon Capital Partners LLC now owns 1,032 shares of the company's stock valued at $39,000 after acquiring an additional 530 shares during the last quarter. Brooklyn Investment Group bought a new position in shares of Keurig Dr Pepper in the third quarter worth about $61,000. Finally, Federated Hermes Inc. grew its holdings in Keurig Dr Pepper by 21.8% during the 2nd quarter. Federated Hermes Inc. now owns 1,757 shares of the company's stock worth $59,000 after acquiring an additional 314 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors.
About Keurig Dr Pepper
(
Get Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also
Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
